SlideShare a Scribd company logo
Warmline, PEPline, Perinatal
Telephone Consultation Service


      NATIONAL HIV/AIDS CLINICIANS’ CONSULTATION CENTER

          WARMLINE, PEPLINE AND PERINATAL HIV HOTLINE


                                 JASON TOKUMOTO, MD

                         Assistant Clinical Professor of Medicine

                   UNIVERSITY OF CALIFORNIA SAN FRANCISCO



DISCLOSURE: DR TOKUMOTO HAS NO FINANCIAL INTERESTS OR RELATIONSHIPS WITH COMMERCIAL ENTITIES WHOSE
               PRODUCTS OR SERVICES ARE RELEVANT TO THE CONTENT OF HIS PRESENTATION.
National HIV/AIDS Clinicians’ Consultation Center
                    UCSF – San Francisco General Hospital
                                   www.nccc.ucsf.edu



WARMLINE            800.933.3413    NATIONAL HIV TELEPHONE CONSULTATION SERVICE


      CONSULTATION ON ALL ASPECTS OF HIV CARE AND TESTING

PEPLINE        888.448.4911 NATIONAL CLINICIANS’ POST-EXPOSURE PROPHYLAXIS HOTLINE

      RECOMMENDATIONS ON MANAGING OCCUPATIONAL(AND NON)EXPOSURES TO
 HIV AND HEPATITIS B & C

PERINATAL HIV HOTLINE               888.448.8765   NATIONAL PERINATAL HIV CONSULTATION AND
 REFERRAL SERVICE
    ADVICE ON TESTING AND CARE OF HIV-INFECTED PREGNANT WOMEN
 ANDTHEIR INFANT. REFERRALS TO HIV-EXPERIENCED CLINICANS AND REGIONAL
 RESOURCES




 HRSA AIDS Education and Training Centers (AETC) Program, HIV/AIDS Bureau
                   & HRSA Community Based Programs
       with additional funding from Centers for Disease Control and Prevention (CDC)
National Clinicians’ Consultation Center (NCCC)
    Warmline, PEPline and Perinatal Hotline

           Physicians
              Internal Medicine
              Infectious Diseases
              Family Medicine
              Ob-Gyn

           Clinical Pharmacists

           -------------------------------------------

           Expert consultation, free of
           charge
Consultations Provided by the NCCC
             Total – 170,000 calls
                                  2011 volume
  Warmline (1992)                  3585

  PEPline   (1997)                 9678

  Perinatal HIV Hotline (2004)      385


                     Total 2011   14,356
                                  (1200/mo)
HIV+ Patient Load of Warmline Callers

                           Warmline Caller's HIV+ Case Load

                     300
Number of Patients




                     250
                     200
                     150
                     100
                     50
                      0
                             0    1-3     4-10   11-25 26-50   51-   101+
                                                               100
                                        Case Load Categories
Profession of Warmline Callers
Profession of Warmline    Percentage
Callers
MD/DO                       66.2%
NP/PA                       14.8%
RN/LVN                      5.6%
Other Medical               4.3%
Pharmacist (PharmD/RPh)     5.3%
Other Nonmedical            1.2%
Dental                      0.5%
Unknown                     2.0%
Facility of Warmline Callers

Facility of Warmline Callers   Percentage
Community Clinic/Migrant         34.5%
Health Center
Private Practice/Ambulatory      18.9%
Hospital                         15.7%
Nonmedical                       4.1%
Outpatient - Other               13.4%
Other Medical/Dental             7.9%
Unknown                          5.4%
Warmline Call Topics
Warmline Call Topics          Percentage
Drug Treatment Strategies       62.9%
Clinical & Laboratory           10.8%
Abnormalities
Management of HIV-related       12.5%
Conditions
Referrals & References          2.9%
Primary Care & Epidemiology     2.8%
Testing & Counseling            5.1%
Transmission & Prevention       2.8%
Warmline


 Provide timely, state-of-the-art, evidence-based, and
     accurate consultation.
        Latest DHHS/CDC guidelines.
        Group consulting.
        Specialty consultation.
        Options.
 Improve consultation technique.
   “Meet caller at where he/she is.”

   Question behind the question.



10
Warmline question-antiretrovirals

 What antiretroviral regimen? (First regimen –
     resistant virus)
        Obtain antiretroviral history.
        Request fax of all resistance tests results.
        Adherence.
        What patient can and will take and do.
        Liver function and renal function.
        Other medications.
        Provide options.




11
Warmline – testing question

 20 week pregnant female with no risk factors for HIV
  undergoes HIV screening test with a 4th generation
  HIV ½ test(tests for both HIV ab and P24 antigens).
 Test is positive, WB indeterminate, P24
  indeterminate.
 One week later, retested. Test is again positive with
  an indeterminate WB; P24 antigen positive with
  RNA PCR and DNA PCR undetectable.
 At 35 weeks, remains positive for the 4th generation
  test with an indeterminate WB(same bands) and P24
  indeterminate.
12
PEPline        888.448.4911
Managing Occupational and Non-Occupational Exposures to Bloodborne Pathogens



       Steps in Managing BBP Exposures
          Assess risk:
             nature of injury and type of fluid
             source patient factors

          Determine whether to offer PEP
          Select PEP regimen
          Obtain baseline laboratory tests
          Counsel the HCW and/or treating clinician
          Follow-up care
Caller

     Treating Clinician                                                  72%

      Caller is exposed                14%

                 Other                 14%

                          0         1000 2000 3000 4000 5000 6000 7000




                        Caller Profession

               MD                                                              42%

RN/NP/PA/CNM/LVN                                                                 45%

   Other/Unknown                         13%

                    0         500     1000   1500   2000   2500   3000    3500   4000
Profession of the Exposed

                     MD                  16%

       RN/NP/PA/CNM/LVN                                         64%

           Other/Unknown                   20%

                           0       200    400    600   800   1000 1200




                    Exposure Setting

                  Hospital                                      26%
                       ED                5%
        OR/L&D/Procedure                        10%
       Outpt/Other Medical                               20%
Dental/Lab/Ambulance/other                                               38%
                               0     500    1000 1500 2000 2500 3000 3500
Exposure Category

    Percutaneous                                                64%

Mucous Membrane                   20%

      Cutaneous                  16%
                      0   1000    2000   3000     4000   5000    6000




                      Exposure Fluid

         Blood                                                  56%

         Saliva                  16%

 Other/Unknown                           28%

                  0       1000    2000     3000      4000       5000
PEPline



No occupational transmission of HIV since 2001.
        Documented US occupational HIV transmission remains at
         56.
        Another 138 possible US occupational HIV transmission.




17
Perinatal


1. Prenatal HIV antiretroviral regimens.
2. Intrapartum issues e.g. rupture membranes, mode
  of delivery.
3. Antiretrovirals(PEP) for the infant.
4. Ruling out HIV in the infant born to an HIV +
  mother.
Work very closely with the HIV ob-gyn specialist.



18

More Related Content

Similar to NCCC Tokumoto

PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
Clinical Care Options
 
Employee Health in Indian Hospitals
Employee Health in Indian HospitalsEmployee Health in Indian Hospitals
Employee Health in Indian HospitalsApollo Hospitals
 
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...
hivlifeinfo
 
Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019
hivlifeinfo
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
Cheryl Johnson
 
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
hivlifeinfo
 
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
hivlifeinfo
 
3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag
3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag
3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag
CDC NPIN
 
Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019
hivlifeinfo
 
Сравнение режимов лечения ВИЧ в разрезе различных клинических сценариев.ART...
Сравнение  режимов лечения ВИЧ в  разрезе различных клинических сценариев.ART...Сравнение  режимов лечения ВИЧ в  разрезе различных клинических сценариев.ART...
Сравнение режимов лечения ВИЧ в разрезе различных клинических сценариев.ART...
hivlifeinfo
 
HIV Transmission in Women: What we Know, Where are the Gaps
HIV Transmission in Women: What we Know, Where are the GapsHIV Transmission in Women: What we Know, Where are the Gaps
HIV Transmission in Women: What we Know, Where are the Gaps
UC San Diego AntiViral Research Center
 
The Extent and Impact of Needlestick Injuries at the Waikato DHB
The Extent and Impact of Needlestick Injuries at the Waikato DHBThe Extent and Impact of Needlestick Injuries at the Waikato DHB
The Extent and Impact of Needlestick Injuries at the Waikato DHB
Occupational Health and Safety Industry Group
 
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
hivlifeinfo
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
Nancy126144
 
std-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfddstd-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfdd
Ralphjeanomurillo
 
sexually transmitted diseases-module.ppt
sexually transmitted diseases-module.pptsexually transmitted diseases-module.ppt
sexually transmitted diseases-module.ppt
RODELAZARES3
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
SuriaKumar4
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
naomikibithe1
 
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Hivlife Info
 

Similar to NCCC Tokumoto (20)

PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
PrEP and My Patients: Guidance for LGBT Community–Based Primary Care Provider...
 
Employee Health in Indian Hospitals
Employee Health in Indian HospitalsEmployee Health in Indian Hospitals
Employee Health in Indian Hospitals
 
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...
Современное лечение ВИЧ: модификация АРТ у пациентов с вирусологической супре...
 
Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019Pharmacy Essentials for HIV Screening and Management.2019
Pharmacy Essentials for HIV Screening and Management.2019
 
Hiv Testing VA Goetz
Hiv Testing VA GoetzHiv Testing VA Goetz
Hiv Testing VA Goetz
 
HIV self-testing and linkage in Africa
HIV self-testing and linkage in AfricaHIV self-testing and linkage in Africa
HIV self-testing and linkage in Africa
 
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
 
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
Современное лечение ВИЧ: новые подходы к оптимизации АРТ/Contemporary Managem...
 
3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag
3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag
3 tue 0800 saag national hiv prevention mtg 2011 test and treat con saag
 
Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019Clinical Impact of New HIV Data From CROI 2019
Clinical Impact of New HIV Data From CROI 2019
 
Сравнение режимов лечения ВИЧ в разрезе различных клинических сценариев.ART...
Сравнение  режимов лечения ВИЧ в  разрезе различных клинических сценариев.ART...Сравнение  режимов лечения ВИЧ в  разрезе различных клинических сценариев.ART...
Сравнение режимов лечения ВИЧ в разрезе различных клинических сценариев.ART...
 
HIV Transmission in Women: What we Know, Where are the Gaps
HIV Transmission in Women: What we Know, Where are the GapsHIV Transmission in Women: What we Know, Where are the Gaps
HIV Transmission in Women: What we Know, Where are the Gaps
 
The Extent and Impact of Needlestick Injuries at the Waikato DHB
The Extent and Impact of Needlestick Injuries at the Waikato DHBThe Extent and Impact of Needlestick Injuries at the Waikato DHB
The Extent and Impact of Needlestick Injuries at the Waikato DHB
 
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
Современное лечение и профилактика ВИЧ : передовые стратегии лечения у пациен...
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
 
std-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfddstd-module.ppt hhhhhjdddddrssssssssssgfdd
std-module.ppt hhhhhjdddddrssssssssssgfdd
 
sexually transmitted diseases-module.ppt
sexually transmitted diseases-module.pptsexually transmitted diseases-module.ppt
sexually transmitted diseases-module.ppt
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
 
std-module.ppt
std-module.pptstd-module.ppt
std-module.ppt
 
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
Highlights of AIDS 2014 .CCO Official Conference Coverage of the 20th Interna...
 

More from HIV_STD_Partners_Meeting

AETC Testing for HIV Infection Bittenbender
AETC Testing for HIV Infection BittenbenderAETC Testing for HIV Infection Bittenbender
AETC Testing for HIV Infection BittenbenderHIV_STD_Partners_Meeting
 
Primary Care Perspective on HIV Treatment Bloomquist
Primary Care Perspective on HIV Treatment BloomquistPrimary Care Perspective on HIV Treatment Bloomquist
Primary Care Perspective on HIV Treatment BloomquistHIV_STD_Partners_Meeting
 
Hep B and C Screening & Management Simons Towns
Hep B and C Screening & Management Simons TownsHep B and C Screening & Management Simons Towns
Hep B and C Screening & Management Simons TownsHIV_STD_Partners_Meeting
 
Patient Benefits Coodinators Suniga Buchanan
Patient Benefits Coodinators Suniga Buchanan Patient Benefits Coodinators Suniga Buchanan
Patient Benefits Coodinators Suniga Buchanan HIV_STD_Partners_Meeting
 

More from HIV_STD_Partners_Meeting (20)

AETC Testing for HIV Infection Bittenbender
AETC Testing for HIV Infection BittenbenderAETC Testing for HIV Infection Bittenbender
AETC Testing for HIV Infection Bittenbender
 
Na Sister Gorman
Na Sister GormanNa Sister Gorman
Na Sister Gorman
 
GLBT Chesbro
GLBT ChesbroGLBT Chesbro
GLBT Chesbro
 
Primary Care Perspective on HIV Treatment Bloomquist
Primary Care Perspective on HIV Treatment BloomquistPrimary Care Perspective on HIV Treatment Bloomquist
Primary Care Perspective on HIV Treatment Bloomquist
 
Telephone Triage Nurse Hoban Pepper
Telephone Triage Nurse Hoban PepperTelephone Triage Nurse Hoban Pepper
Telephone Triage Nurse Hoban Pepper
 
HCV Tx Update 2012 Townshend
HCV Tx Update 2012 TownshendHCV Tx Update 2012 Townshend
HCV Tx Update 2012 Townshend
 
STD Cases for HIV Care Providers Adler
STD Cases for HIV Care Providers Adler STD Cases for HIV Care Providers Adler
STD Cases for HIV Care Providers Adler
 
Hep B and C Screening & Management Simons Towns
Hep B and C Screening & Management Simons TownsHep B and C Screening & Management Simons Towns
Hep B and C Screening & Management Simons Towns
 
Telemed HCV HIV Townshend Simsons
Telemed HCV HIV Townshend SimsonsTelemed HCV HIV Townshend Simsons
Telemed HCV HIV Townshend Simsons
 
Use your Pharmacist Huentelman
Use your Pharmacist HuentelmanUse your Pharmacist Huentelman
Use your Pharmacist Huentelman
 
Selecting an Intervention Chesbro
Selecting an Intervention ChesbroSelecting an Intervention Chesbro
Selecting an Intervention Chesbro
 
Patient Benefits Coodinators Suniga Buchanan
Patient Benefits Coodinators Suniga Buchanan Patient Benefits Coodinators Suniga Buchanan
Patient Benefits Coodinators Suniga Buchanan
 
Overview Neel Reilley
Overview Neel Reilley Overview Neel Reilley
Overview Neel Reilley
 
Keynote Iralu
Keynote IraluKeynote Iralu
Keynote Iralu
 
Innovations STI Coleman White Earth
Innovations STI Coleman White EarthInnovations STI Coleman White Earth
Innovations STI Coleman White Earth
 
Homebased Care Shin
Homebased Care ShinHomebased Care Shin
Homebased Care Shin
 
HIV Opportunistic Infections Iralu
HIV Opportunistic Infections IraluHIV Opportunistic Infections Iralu
HIV Opportunistic Infections Iralu
 
GPRA Fox Fristol Bay Alaska
GPRA Fox Fristol Bay AlaskaGPRA Fox Fristol Bay Alaska
GPRA Fox Fristol Bay Alaska
 
GPRA Anderson Choctoaw Nation
GPRA Anderson Choctoaw NationGPRA Anderson Choctoaw Nation
GPRA Anderson Choctoaw Nation
 
Community Engagement Hoagie
Community Engagement HoagieCommunity Engagement Hoagie
Community Engagement Hoagie
 

Recently uploaded

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
Dr. Vinay Pareek
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
Swetaba Besh
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
Thangamjayarani
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Prof. Marcus Renato de Carvalho
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
MedicoseAcademics
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
د.محمود نجيب
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
Dr. Rabia Inam Gandapore
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
MedicoseAcademics
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
Krishan Murari
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
Lighthouse Retreat
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
Dr. Jyothirmai Paindla
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
MedicoseAcademics
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
Little Cross Family Clinic
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
FFragrant
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
ShashankRoodkee
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
NEHA GUPTA
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
NEHA GUPTA
 

Recently uploaded (20)

ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTSARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
ARTHROLOGY PPT NCISM SYLLABUS AYURVEDA STUDENTS
 
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptxANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx
 
planning for change nursing Management ppt
planning for change nursing Management pptplanning for change nursing Management ppt
planning for change nursing Management ppt
 
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidadeNovas diretrizes da OMS para os cuidados perinatais de mais qualidade
Novas diretrizes da OMS para os cuidados perinatais de mais qualidade
 
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptxPharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx
 
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptxMaxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
Maxilla, Mandible & Hyoid Bone & Clinical Correlations by Dr. RIG.pptx
 
Physiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdfPhysiology of Chemical Sensation of smell.pdf
Physiology of Chemical Sensation of smell.pdf
 
KDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologistsKDIGO 2024 guidelines for diabetologists
KDIGO 2024 guidelines for diabetologists
 
Cervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptxCervical & Brachial Plexus By Dr. RIG.pptx
Cervical & Brachial Plexus By Dr. RIG.pptx
 
Non-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdfNon-respiratory Functions of the Lungs.pdf
Non-respiratory Functions of the Lungs.pdf
 
BRACHYTHERAPY OVERVIEW AND APPLICATORS
BRACHYTHERAPY OVERVIEW  AND  APPLICATORSBRACHYTHERAPY OVERVIEW  AND  APPLICATORS
BRACHYTHERAPY OVERVIEW AND APPLICATORS
 
Light House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat EuropeLight House Retreats: Plant Medicine Retreat Europe
Light House Retreats: Plant Medicine Retreat Europe
 
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptxThyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx
 
A Classical Text Review on Basavarajeeyam
A Classical Text Review on BasavarajeeyamA Classical Text Review on Basavarajeeyam
A Classical Text Review on Basavarajeeyam
 
Physiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of TastePhysiology of Special Chemical Sensation of Taste
Physiology of Special Chemical Sensation of Taste
 
Are There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdfAre There Any Natural Remedies To Treat Syphilis.pdf
Are There Any Natural Remedies To Treat Syphilis.pdf
 
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptxHow STIs Influence the Development of Pelvic Inflammatory Disease.pptx
How STIs Influence the Development of Pelvic Inflammatory Disease.pptx
 
Sex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skullSex determination from mandible pelvis and skull
Sex determination from mandible pelvis and skull
 
New Drug Discovery and Development .....
New Drug Discovery and Development .....New Drug Discovery and Development .....
New Drug Discovery and Development .....
 
CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}CDSCO and Phamacovigilance {Regulatory body in India}
CDSCO and Phamacovigilance {Regulatory body in India}
 

NCCC Tokumoto

  • 1. Warmline, PEPline, Perinatal Telephone Consultation Service NATIONAL HIV/AIDS CLINICIANS’ CONSULTATION CENTER WARMLINE, PEPLINE AND PERINATAL HIV HOTLINE JASON TOKUMOTO, MD Assistant Clinical Professor of Medicine UNIVERSITY OF CALIFORNIA SAN FRANCISCO DISCLOSURE: DR TOKUMOTO HAS NO FINANCIAL INTERESTS OR RELATIONSHIPS WITH COMMERCIAL ENTITIES WHOSE PRODUCTS OR SERVICES ARE RELEVANT TO THE CONTENT OF HIS PRESENTATION.
  • 2. National HIV/AIDS Clinicians’ Consultation Center UCSF – San Francisco General Hospital www.nccc.ucsf.edu WARMLINE 800.933.3413 NATIONAL HIV TELEPHONE CONSULTATION SERVICE CONSULTATION ON ALL ASPECTS OF HIV CARE AND TESTING PEPLINE 888.448.4911 NATIONAL CLINICIANS’ POST-EXPOSURE PROPHYLAXIS HOTLINE RECOMMENDATIONS ON MANAGING OCCUPATIONAL(AND NON)EXPOSURES TO HIV AND HEPATITIS B & C PERINATAL HIV HOTLINE 888.448.8765 NATIONAL PERINATAL HIV CONSULTATION AND REFERRAL SERVICE ADVICE ON TESTING AND CARE OF HIV-INFECTED PREGNANT WOMEN ANDTHEIR INFANT. REFERRALS TO HIV-EXPERIENCED CLINICANS AND REGIONAL RESOURCES HRSA AIDS Education and Training Centers (AETC) Program, HIV/AIDS Bureau & HRSA Community Based Programs with additional funding from Centers for Disease Control and Prevention (CDC)
  • 3.
  • 4. National Clinicians’ Consultation Center (NCCC) Warmline, PEPline and Perinatal Hotline Physicians Internal Medicine Infectious Diseases Family Medicine Ob-Gyn Clinical Pharmacists ------------------------------------------- Expert consultation, free of charge
  • 5. Consultations Provided by the NCCC Total – 170,000 calls 2011 volume Warmline (1992) 3585 PEPline (1997) 9678 Perinatal HIV Hotline (2004) 385 Total 2011 14,356 (1200/mo)
  • 6. HIV+ Patient Load of Warmline Callers Warmline Caller's HIV+ Case Load 300 Number of Patients 250 200 150 100 50 0 0 1-3 4-10 11-25 26-50 51- 101+ 100 Case Load Categories
  • 7. Profession of Warmline Callers Profession of Warmline Percentage Callers MD/DO 66.2% NP/PA 14.8% RN/LVN 5.6% Other Medical 4.3% Pharmacist (PharmD/RPh) 5.3% Other Nonmedical 1.2% Dental 0.5% Unknown 2.0%
  • 8. Facility of Warmline Callers Facility of Warmline Callers Percentage Community Clinic/Migrant 34.5% Health Center Private Practice/Ambulatory 18.9% Hospital 15.7% Nonmedical 4.1% Outpatient - Other 13.4% Other Medical/Dental 7.9% Unknown 5.4%
  • 9. Warmline Call Topics Warmline Call Topics Percentage Drug Treatment Strategies 62.9% Clinical & Laboratory 10.8% Abnormalities Management of HIV-related 12.5% Conditions Referrals & References 2.9% Primary Care & Epidemiology 2.8% Testing & Counseling 5.1% Transmission & Prevention 2.8%
  • 10. Warmline  Provide timely, state-of-the-art, evidence-based, and accurate consultation.  Latest DHHS/CDC guidelines.  Group consulting.  Specialty consultation.  Options.  Improve consultation technique.  “Meet caller at where he/she is.”  Question behind the question. 10
  • 11. Warmline question-antiretrovirals  What antiretroviral regimen? (First regimen – resistant virus)  Obtain antiretroviral history.  Request fax of all resistance tests results.  Adherence.  What patient can and will take and do.  Liver function and renal function.  Other medications.  Provide options. 11
  • 12. Warmline – testing question  20 week pregnant female with no risk factors for HIV undergoes HIV screening test with a 4th generation HIV ½ test(tests for both HIV ab and P24 antigens).  Test is positive, WB indeterminate, P24 indeterminate.  One week later, retested. Test is again positive with an indeterminate WB; P24 antigen positive with RNA PCR and DNA PCR undetectable.  At 35 weeks, remains positive for the 4th generation test with an indeterminate WB(same bands) and P24 indeterminate. 12
  • 13. PEPline 888.448.4911 Managing Occupational and Non-Occupational Exposures to Bloodborne Pathogens Steps in Managing BBP Exposures Assess risk:  nature of injury and type of fluid  source patient factors Determine whether to offer PEP Select PEP regimen Obtain baseline laboratory tests Counsel the HCW and/or treating clinician Follow-up care
  • 14. Caller Treating Clinician 72% Caller is exposed 14% Other 14% 0 1000 2000 3000 4000 5000 6000 7000 Caller Profession MD 42% RN/NP/PA/CNM/LVN 45% Other/Unknown 13% 0 500 1000 1500 2000 2500 3000 3500 4000
  • 15. Profession of the Exposed MD 16% RN/NP/PA/CNM/LVN 64% Other/Unknown 20% 0 200 400 600 800 1000 1200 Exposure Setting Hospital 26% ED 5% OR/L&D/Procedure 10% Outpt/Other Medical 20% Dental/Lab/Ambulance/other 38% 0 500 1000 1500 2000 2500 3000 3500
  • 16. Exposure Category Percutaneous 64% Mucous Membrane 20% Cutaneous 16% 0 1000 2000 3000 4000 5000 6000 Exposure Fluid Blood 56% Saliva 16% Other/Unknown 28% 0 1000 2000 3000 4000 5000
  • 17. PEPline No occupational transmission of HIV since 2001.  Documented US occupational HIV transmission remains at 56.  Another 138 possible US occupational HIV transmission. 17
  • 18. Perinatal 1. Prenatal HIV antiretroviral regimens. 2. Intrapartum issues e.g. rupture membranes, mode of delivery. 3. Antiretrovirals(PEP) for the infant. 4. Ruling out HIV in the infant born to an HIV + mother. Work very closely with the HIV ob-gyn specialist. 18